EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of sIgE Qualitative Conversion and Clinical Response to HDMs Sublingual Immunotherapy: Insights from Three Immunoassays

Tarek Gheith, Sherihan M Rohayem, Atef Taha El Bahrawy, Amira E Mesbah iD, Safaa Gaber Aly Salem, Noha M Hammad iD

Biomolecules · 18.06.2026 · 16 (6) · 905

DOI: 10.3390/biom16060905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.06.2026. Verfasst von Tarek Gheith und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Immunoglobulin E, Pyroglyphidae, Rhinitis, Allergic. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sublingual immunotherapy (SLIT) is an effective treatment for house dust mite (HDM)-induced allergic rhinitis (AR); however, the significance of qualitative changes in specific IgE (sIgE) remains unclear. This study evaluated post-treatment changes in sIgE reactivity and compared the performance of three immunoassays.

Methods

In this prospective study, monosensitized patients with HDM-induced AR were identified using skin prick testing and followed for 12 months after SLIT. Serum sIgE levels were assessed at baseline and after treatment using immunoblot, chemiluminescent immunoassay (CLIA), and ImmunoCAP as the reference method. Qualitative changes in sIgE reactivity were analyzed. Clinical response was assessed using the total nasal symptom score (TNSS), and total IgE (tIgE) levels were measured.

Results

At baseline, HDM-sIgE reactivity was detected in 85.7%, 82.1%, and 92.9% of patients by immunoblot, CLIA, and ImmunoCAP, respectively. Following SLIT, a significant qualitative conversion to non-reactive status was observed across all assays (p < 0.001). Conversion rates were 94.0% for immunoblot, 83.3% for CLIA, and 100.0% for ImmunoCAP. Significant improvements in TNSS and reductions in tIgE were also observed.

Conclusions

SLIT induces a marked qualitative reduction in HDM-sIgE reactivity, with complete serological conversion detected by ImmunoCAP. Although the immunoassays showed comparable rates of HDM-sIgE detection, their agreement in classifying individual patients differed, indicating variability in assay performance. Qualitative assessment of sIgE may provide a clinically meaningful approach for monitoring immunotherapy response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sublingual ImmunotherapyImmunoglobulin EPyroglyphidaeRhinitis, AllergicDust Mite AllergyHumansFemaleImmunoassayMaleAnimalsAdultProspective StudiesAdolescentYoung AdultMiddle AgedAntigens, Dermatophagoides

Stichwörter der Autor:innen

CLIAImmunoCAPSLITimmunoblotqualitative IgE conversion

Substanzen

Immunoglobulin EAntigens, Dermatophagoides

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Portsaid University, Portsaid 42511, Egypt.
  • Department of Otorhinolaryngology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
  • Department of Acarology, Plant Protection Research Institute, Agricultural Research Center, Giza 12611, Egypt.
  • Department of Maternity, Obst & Gyn Nursing, College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Al Jouf Regional Laboratory, Shared Services, Ministry of Health, Sakaka 73244, Saudi Arabia.

ORCID-Profile: Amira E Mesbah, Noha M Hammad

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Gheith, T., Rohayem, S. M., El Bahrawy, A. T., Mesbah, A. E., Salem, S. G. A., & Hammad, N. M. (2026). Evaluation of sIgE Qualitative Conversion and Clinical Response to HDMs Sublingual Immunotherapy: Insights from Three Immunoassays. Biomolecules, 16(6), 905. https://doi.org/10.3390/biom16060905

Vancouver

Gheith T, Rohayem SM, El Bahrawy AT, Mesbah AE, Salem SGA, Hammad NM. Evaluation of sIgE Qualitative Conversion and Clinical Response to HDMs Sublingual Immunotherapy: Insights from Three Immunoassays. Biomolecules. 2026;16(6):905. doi:10.3390/biom16060905

BibTeX
@article{Gheith2026,
  author = {Gheith, Tarek and Rohayem, Sherihan M and El Bahrawy, Atef Taha and Mesbah, Amira E and Salem, Safaa Gaber Aly and Hammad, Noha M},
  title = {Evaluation of sIgE Qualitative Conversion and Clinical Response to HDMs Sublingual Immunotherapy: Insights from Three Immunoassays},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {905},
  doi = {10.3390/biom16060905}
}
Kostenlos starten →